Trending Now
LATEST ARTICLES
Ninety-Three Studies Reopened Pharma’s Oldest Marketing Question: How Much Influence Is Too Much?
A new Cochrane review has reopened one of pharmaceutical marketing's most uncomfortable questions: when does professional engagement become undue influence? Examining 93 studies, researchers...
Kidney Patients Aren’t Just an Audience Anymore. They’re Becoming a Constituency.
For years, pharmaceutical companies have approached patient advocacy through education campaigns, disease awareness programs, and partnerships with patient organizations. However, the American Association of...
What If Patient Ambassadors Were Your Best Research Team?
What if your most valuable research team already understood your patients because they were patients themselves? Could a patient ambassador strategy built around continuous...
A Prescription Wearable Went on TV. The Funnel Looks Nothing Like Pharma’s Usual One.
The way prescription medical devices reach consumers is changing, and Osteoboost's national television campaign offers a revealing example of that shift. In September 2026,...
“I’ll Start Therapy When Life Calms Down.” Rula Tried to Remove the Excuse.
People often know they need mental health support. However, knowing and acting are two different things. Between work, family responsibilities, and endless household chores,...
The Campaign Wasn’t the Only Risk. The Governance Broke Down Too.
When it comes to pharma marketing governance, companies often focus on what the public sees: advertisements, claims, sponsorship messages, and promotional content. However, some...
India Is Rethinking Pharma Promotion. Why Global Brands Should Pay Attention
India may be rewriting the rules of pharmaceutical promotion, and multinational drugmakers have good reason to pay attention. As pharma marketing regulation faces renewed...
The Ad Said $39. Checkout Said More. When Does Price Become a Marketing Claim?
An online ad promises a $39 price. You click, compare options, and prepare to buy. However, the final bill tells a different story. That...
A Pharma Company Is Calling for a Women’s Health Strategy. Is Category Advocacy Becoming...
A pharmaceutical company usually builds relevance around a medicine. Organon is taking a wider approach. Its call for a coordinated European women’s health strategy...
Merck’s HIV “Hive” Puts the Support Network at the Center
Merck’s Your Hive of Whole Health initiative offers pharmaceutical marketers a useful lesson in whole-person patient engagement: the patient journey does not happen between...
